je.st
news
Tag: lung
Actelion Rises After Winning Approval of Opsumit Lung Medicine
2013-10-21 11:15:34| Biotech - Topix.net
Actelion Ltd. rose the most in more than 17 months after winning U.S. approval for the lung drug Opsumit, giving the Swiss company a successor to a best-selling medicine that loses patent protection in late 2015.
Tags: medicine
approval
winning
lung
Certara Partners With Critical Path Institute To Develop Population-Based Lung Model To Test New Tuberculosis Drugs
2013-10-02 05:59:57| drugdiscoveryonline News Articles
Certara, a leading provider of software and scientific consulting services to improve productivity and decision-making from drug discovery through drug development, recently announced that it is partnering with the Critical Path Institute (“C-Path”) to develop a physiologically-based pharmacokinetic (PBPK) model of the human lung
Tags: test
model
partners
develop
Interim Data for Mercks MK-3475, an Investigational Anti-PD-1 Immunotherapy, in Previously Treated Patients with Non-Small Cell Lung Cancer to be Presented at 15th World Conference on Lung Cancer
2013-10-01 19:00:00| Merck.com - Research & Development News
Dateline City: WHITEHOUSE STATION, N.J. WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, confirmed today that interim data from the companys Phase IB expansion study (PN 001) evaluating the efficacy and safety of *MK-3475 in patients with refractory non-small cell lung cancer (NSCLC) is scheduled for presentation at the 15th World Conference on Lung Cancer on Oct. 29 at 4:15 p.m., (1:15 a.m. EDT), in Sydney, Australia. Language: English Contact: MerckMedia:Caroline Lappetito, 267-305-7639Claire Mulhearn, 908-423-7425orInvestor:Carol Ferguson, 908-423-4465Justin Holko, 908-423-5088 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Varian's Calypso Tumor Tracking System Used in Lung, Stomach, and Prostate Cancer Treatments ...
2013-09-30 06:00:00| Industrial Newsroom - All News for Today
Lisbon, Portugal – Clinicians in Lisbon have commenced advanced radiosurgery treatments using Varian's Calypso® 'GPS for the Body' real-time tumor tracking system. Doctors at the 'Champalimaud Center for the Unknown' (CCU) utilized the Calypso system to enhance precision during a radiosurgery treatment that included the world's first clinical use of the new commercially available Calypso lung Beacon® transponder. <br /> <br /> The center has used this method to treat three patients with ...This story is related to the following:Health, Medical and Dental Supplies and EquipmentSearch for suppliers of: Tracking Systems | Radiotherapy Systems |
Tags: system
cancer
tracking
treatments
ArQule up on hope for lung cancer drug revival
2013-09-28 06:28:45| Biotech - Topix.net
Our day's top images, in-depth photo essays and offbeat slices of life. See the best of Reuters photography.
Sites : [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] next »